These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15354402)

  • 1. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers.
    Romano F; Uggeri F; Crippa S; Di Stefano G; Scotti M; Scaini A; Caprotti R; Uggeri F
    J Exp Clin Cancer Res; 2004 Jun; 23(2):195-200. PubMed ID: 15354402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical surgery does not recover immunodeficiency associated with gastric cancer.
    Romano F; Caprotti R; Bravo AF; Conti M; Colombo G; Piacentini G; Uggeri F; Uggeri F
    J Exp Clin Cancer Res; 2003 Jun; 22(2):179-83. PubMed ID: 12866567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F
    Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients.
    Mussi C; Angelini C; Crippa S; Caprotti R; Fumagalli L; Motta V; Uggeri F
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxxviii-ccxxxi. PubMed ID: 15244187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of hypothalamus-pituitary-adrenal gland axis in colorectal cancer patients. Preliminary report.
    Crippa S; Mussi C; Angelini C; Caprotti R; Bonardi C; Muselli P; Scotti M; Piacentini G; Uggeri F
    Minerva Chir; 2003 Aug; 58(4):581-5. PubMed ID: 14603172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study.
    Franciosi CM; Piacentini MG; Conti M; Romano F; Musco F; Caprotti R; Rovelli F; Uggeri F
    Hepatogastroenterology; 2003; 50(49):297-300. PubMed ID: 12630045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of perioperative cimetidine administration on peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: results of a randomized controlled clinical trial.
    Li Y; Yang GL; Yuan HY; Bai DJ; Wang K; Lin CR; Hu MB; Feng MH
    Hepatogastroenterology; 2005; 52(62):504-8. PubMed ID: 15816467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
    Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
    Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term preoperative IL-2 immunotherapy in operable pancreatic cancer: a randomized study.
    Uggeri F; Caprotti R; De Grate L; Crippa S; Nobili C; Penati C; Romano F
    Hepatogastroenterology; 2009; 56(91-92):861-5. PubMed ID: 19621718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic resection induces a shift in the Th 1/2 balance toward Th 2 and produces hypermetabolic and hyperhemodynamic states.
    Ishikawa M; Nishioka M; Hanaki N; Miyauchi T; Kashiwagi Y; Miki H
    Hepatogastroenterology; 2004; 51(59):1422-7. PubMed ID: 15362768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women.
    Merhi ZO; Durkin HG; Feldman J; Macura J; Rodriguez C; Minkoff H
    Surg Obes Relat Dis; 2009; 5(2):165-71. PubMed ID: 18996763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery-induced decline in circulating dendritic cells in operable cancer patients: a possible explanation of postoperative immunosuppression.
    Brivio F; Gilardi R; Bucocev R; Ferrante R; Rescaldani R; Vigoré L; Fumagalli L; Nespoli A; Lissoni P
    Hepatogastroenterology; 2000; 47(35):1337-9. PubMed ID: 11100346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
    Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
    J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of a method of reconstruction after pancreatoduodenectomy.
    Lygidakis NJ; Jain S; Sacchi M; Vrachnos P
    Hepatogastroenterology; 2005; 52(64):1077-82. PubMed ID: 16001633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients.
    Cerea K; Romano F; Bravo AF; Motta V; Uggeri F; Brivio F; Fumagalli LA; Uggeri F
    J Surg Oncol; 2001 Sep; 78(1):32-7. PubMed ID: 11519066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.